Withdrawn: The novel TRPA1 antagonist BI01305834 inhibits ovalbumin-induced bronchoconstriction in guinea pigs.

Authors

• van den Berg, Mariska^{1, 2}
• Nijboer-Brinksma, Susan^{1, 2}
• Bos, Sophie^{1, 2}
• van den Berge, Maarten^{2, 3}
• Lamb, David⁴
• van Faassen, Martijn⁵
• Kema, Ido⁵
• Gosens, Reinoud^{1, 2}
• Kistemaker, Loes^{1, 2}

• ¹ Department of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands. , (Netherlands)
• ² Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. , (Netherlands)
• ³ Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. , (Netherlands)
• ⁴ Immunology and Respiratory, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany. , (Germany)
• ⁵ Department of Laboratory Medicine, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands. , (Netherlands)

Type

Published Article

Journal

British Journal of Pharmacology

Publisher

Wiley (Blackwell Publishing)

Publication Date

Oct 01, 2020

Volume

177

Issue

20

Pages

4809–4809

Identifiers

DOI: 10.1111/bph.15133

PMID: 32436213

Source

Medline

Language

English

License

Unknown